I am Chief Therapeutics & Clinical Strategy Officer and President of Europe at Worldwide Clinical Trials, where I lead enterprise therapeutic and clinical strategy, strengthen the company’s scientific positioning, and support the development and delivery of complex, globally integrated clinical programmes. I bring more than 35-years of experience across academic institutions, private and public biotechnology companies, pharmaceutical organisations and global CROs. My career spans the full development continuum, from translational research, biomarkers and first-in-human studies through global clinical development, regulatory approval, HTA engagement, lifecycle management, capital formation and commercial execution.